A M Leitch Selected Research

Breast Neoplasms (Breast Cancer)

1/2017	Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial.
6/2001	MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A M Leitch Research Topics

Disease

2	Neoplasms (Cancer) 01/2017 - 06/2001
2	Breast Neoplasms (Breast Cancer) 01/2017 - 06/2001
1	Pathologic Complete Response 01/2017

Drug/Important Bio-Agent (IBA)

1	RNA (Ribonucleic Acid)IBA 01/2017
1	Trastuzumab (Herceptin)FDA Link 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2017 - 06/2001
1	Neoadjuvant Therapy 01/2017